Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast.

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...